Global X Aging Population ETF Rating Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Global X Aging Population ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AGNG Aggregate RatingModerate Buy 2.66Holdings in AGNG have an aggregate rating of Moderate Buy based on 500 analyst ratings issued in the past year covering 32 companies (57.7% of the portfolio).AGNG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Aging Population ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 AGNG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.32%WELLWelltower$129.23+0.4%3.7188 of 5 stars2.83$125.86 -2.6%12Analyst ForecastPositive News3.68%BSXBoston Scientific$90.41-0.1%4.5356 of 5 stars2.91$95.52 5.7%23Analyst ForecastShort Interest ↑3.36%BMYBristol-Myers Squibb$57.65+3.2%4.821 of 5 stars2.25$55.64 -3.5%20Dividend IncreaseAnalyst UpgradePositive News3.16%SYKStryker$370.75-0.5%4.9043 of 5 stars2.85$404.35 9.1%20Positive News3.04%ABBVAbbVie$175.42+2.2%4.9486 of 5 stars2.88$205.70 17.3%24Analyst Forecast2.93%MDTMedtronic$81.37+0.0%4.9715 of 5 stars2.41$95.27 17.1%17Options VolumePositive News2.92%JNJJohnson & Johnson$146.39+1.8%4.9202 of 5 stars2.50$174.73 19.4%14Positive News2.92%LLYEli Lilly and Company$778.30-0.1%4.9951 of 5 stars2.81$1,002.22 28.8%21Buyback Announcement2.91%AMGNAmgen$265.95-0.2%4.5973 of 5 stars2.42$319.68 20.2%26Analyst Downgrade2.68%AZNAstraZeneca$67.18+1.4%4.2204 of 5 stars2.91$89.75 33.6%11Short Interest ↓2.30%REGNRegeneron Pharmaceuticals$740.01+2.1%4.7088 of 5 stars2.70$1,052.90 42.3%23Analyst Forecast2.19%EWEdwards Lifesciences$74.15+0.3%4.0018 of 5 stars2.42$79.40 7.1%26Analyst UpgradeInsider TradeAnalyst Revision2.19%VTRVentas$60.23+1.3%3.1606 of 5 stars3.00$65.63 9.0%9Positive News1.92%ZBHZimmer Biomet$108.08+1.2%4.7627 of 5 stars2.25$123.28 14.1%20Analyst Upgrade1.58%PODDInsulet$263.35-0.8%4.3595 of 5 stars2.81$267.44 1.6%161.56%BGNEBeiGene$179.06+1.5%2.6509 of 5 stars2.75$253.69 41.7%81.56%DXCMDexCom$77.80+1.8%4.9889 of 5 stars2.72$98.00 26.0%18Short Interest ↓1.50%UTHRUnited Therapeutics$379.69+1.8%4.7106 of 5 stars2.73$370.86 -2.3%15Positive News1.42%INCYIncyte$69.40-0.6%4.4745 of 5 stars2.35$76.18 9.8%20Analyst Forecast1.25%DVADaVita$147.53-2.0%4.3449 of 5 stars2.00$161.80 9.7%5Positive News1.08%NBIXNeurocrine Biosciences$136.69+2.7%4.8855 of 5 stars2.83$166.00 21.4%23Analyst ForecastPositive News0.93%EXELExelixis$34.69-3.8%4.5611 of 5 stars2.58$31.88 -8.1%19Analyst DowngradeShort Interest ↑0.92%EXASExact Sciences$60.37-0.6%4.6099 of 5 stars2.94$72.94 20.8%180.85%OHIOmega Healthcare Investors$39.34+0.8%4.4953 of 5 stars2.50$40.18 2.1%12Positive News0.76%TFXTeleflex$178.28+0.6%4.9112 of 5 stars2.63$259.00 45.3%8Analyst Forecast0.70%ENSGThe Ensign Group$140.00-1.7%4.9827 of 5 stars2.83$164.33 17.4%6Dividend IncreasePositive News0.59%GKOSGlaukos$146.36+1.5%4.1573 of 5 stars2.85$143.17 -2.2%13Short Interest ↓0.54%AGIOAgios Pharmaceuticals$41.96-1.7%4.3314 of 5 stars2.50$56.33 34.3%8Analyst Revision0.51%HALOHalozyme Therapeutics$48.60+1.2%4.9931 of 5 stars2.60$61.11 25.7%10Positive News0.51%MMSIMerit Medical Systems$99.00-3.2%4.4411 of 5 stars3.00$105.09 6.2%120.49%BPMCBlueprint Medicines$96.48+1.1%2.7364 of 5 stars2.71$122.11 26.6%21Insider TradeShort Interest ↑0.47%EMBCEmbecta$19.82-0.9%4.0967 of 5 stars2.50$23.00 16.0%2Short Interest ↓ This page (NASDAQ:AGNG) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Aging Population ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Aging Population ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
